Despite posting robust quarterly earnings and initiating a substantial share repurchase plan, Morningstar’s stock continues to struggle with significant price depreciation throughout 2025. The financial data and research firm finds itself in a curious position, demonstrating operational strength while its equity value faces persistent downward pressure.
Share Buyback Program and Shareholder Returns
In a decisive capital allocation move, Morningstar’s board has authorized a new three-year share repurchase authorization valued at $1 billion. This program, effective October 31, 2025, replaces the previous $500 million buyback initiative. This substantial capital return effort represents a potentially powerful support mechanism for the underperforming security.
Complementing the capital return strategy, the company maintains its commitment to regular dividend distributions. A quarterly dividend payment of $0.455 per share was disbursed to shareholders on October 31.
Strong Operational Performance Contrasts With Market Performance
Morningstar’s third-quarter 2025 financial results revealed net earnings of $91.6 million, equivalent to $2.17 per share. On an adjusted basis, earnings reached $2.55 per share. Revenue climbed 8.4% to $617.4 million, with organic growth registering an even stronger 9.0% increase.
The company’s operational metrics showed particular strength, with adjusted operating income advancing 15.6% and margins expanding by 150 basis points. The Morningstar Credit segment delivered exceptional performance, recording an 84.9% surge in adjusted operating profit.
Should investors sell immediately? Or is it worth buying Morningstar?
Strategic Acquisition and Analyst Perspective
Concurrently with its capital management activities, Morningstar is bolstering its core business operations through the strategic acquisition of the Center for Research in Security Prices (CRSP) from the University of Chicago for $375 million. This transaction is expected to significantly enhance the company’s index business while expanding its investment data and analytics offerings.
Despite the stock’s weakness, analytical sentiment remains cautiously optimistic. BMO Capital maintains its “Outperform” rating on Morningstar shares, though it reduced its price target from $274 to $250. This revised target still implies substantial upside potential from current trading levels.
Technical Picture and Market Performance
Morningstar equity has declined 37.6% year-to-date in 2025, reflecting significant investor pessimism. The security touched a 52-week low of $230.06 on October 1 and currently trades around $215. Technical indicators suggest the stock may be in oversold territory, potentially setting the stage for a reversal if fundamental improvements gain investor recognition.
The critical question remains whether these combined strategic initiatives—substantial share repurchases, continued dividends, strategic acquisition, and solid operational performance—can collectively catalyze a sustained recovery in Morningstar’s market valuation.
Ad
Morningstar Stock: Buy or Sell?! New Morningstar Analysis from October 31 delivers the answer:
The latest Morningstar figures speak for themselves: Urgent action needed for Morningstar investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 31.
Morningstar: Buy or sell? Read more here...
